ES2043834T3 - Un procedimiento para preparar nuevos derivados de androsta-1,4-dien-3-ona sustituida en la posicion 17. - Google Patents

Un procedimiento para preparar nuevos derivados de androsta-1,4-dien-3-ona sustituida en la posicion 17.

Info

Publication number
ES2043834T3
ES2043834T3 ES88308104T ES88308104T ES2043834T3 ES 2043834 T3 ES2043834 T3 ES 2043834T3 ES 88308104 T ES88308104 T ES 88308104T ES 88308104 T ES88308104 T ES 88308104T ES 2043834 T3 ES2043834 T3 ES 2043834T3
Authority
ES
Spain
Prior art keywords
alkyl
hydrogen
androsta
dien
procedure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES88308104T
Other languages
English (en)
Inventor
Vittoria Villa
Salle Enrico Di
Paolo Lombardi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Italia SRL
Original Assignee
Farmitalia Carlo Erba SRL
Carlo Erba SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Farmitalia Carlo Erba SRL, Carlo Erba SpA filed Critical Farmitalia Carlo Erba SRL
Application granted granted Critical
Publication of ES2043834T3 publication Critical patent/ES2043834T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0018—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa
    • C07J1/0022—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/001—Oxiranes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Superconductors And Manufacturing Methods Therefor (AREA)
  • Mounting, Exchange, And Manufacturing Of Dies (AREA)
  • Catalysts (AREA)

Abstract

LA INVENCION SE REFIERE A NUEVOS DERIVADOS DE ANDROSTA - 1,4 DIENO - 3 - ONA - 17 - HIDROXILADOS DE FORMULA(I), DONDE R Y R3 SON INDEPENDIENTEMENTE H O C1 - C6 ALQUILO; R2 ES H O C1 - C6 ALQUILO; R4 ES H O FLUOR; R5 ES A) H O C1 - C6 ALQUILO; B) FENILO SUSTITUIDO O NO POR UNO O DOS SUSTITUYENTES INDEPENDIENTEMENTE ELEGIDOS ENTRE C1 - C6 ALQUILO, HALOGENO Y AMINO; C) UN GRUPO ACILO; O D) UN GRUPO PROTECTOR HIDROXI; Y LAS SALES DE ESTO FARMACEUTICAMENTE ACEPTABLES, QUE SON UTILES EN TERAPIA, EN ESPECIAL COMO ANTICANCERIGENOS.
ES88308104T 1987-09-11 1988-09-01 Un procedimiento para preparar nuevos derivados de androsta-1,4-dien-3-ona sustituida en la posicion 17. Expired - Lifetime ES2043834T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB878721384A GB8721384D0 (en) 1987-09-11 1987-09-11 17-substituted andro-sta-1 4-dien-3-one derivatives

Publications (1)

Publication Number Publication Date
ES2043834T3 true ES2043834T3 (es) 1994-01-01

Family

ID=10623619

Family Applications (1)

Application Number Title Priority Date Filing Date
ES88308104T Expired - Lifetime ES2043834T3 (es) 1987-09-11 1988-09-01 Un procedimiento para preparar nuevos derivados de androsta-1,4-dien-3-ona sustituida en la posicion 17.

Country Status (14)

Country Link
US (1) US4873233A (es)
EP (1) EP0307135B1 (es)
JP (1) JP2677626B2 (es)
KR (1) KR970007948B1 (es)
AT (1) ATE79629T1 (es)
AU (1) AU602607B2 (es)
CA (1) CA1305699C (es)
DE (1) DE3873862T2 (es)
ES (1) ES2043834T3 (es)
FI (1) FI88393C (es)
GB (1) GB8721384D0 (es)
GR (1) GR3005961T3 (es)
IL (1) IL87656A (es)
SU (1) SU1750431A3 (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH683151A5 (de) * 1991-04-24 1994-01-31 Ciba Geigy Ag Antikonzeption bei weiblichen Primaten ohne Beeinflussung des menstruellen Zyklus.
FR2681069B1 (fr) * 1991-09-06 1995-04-28 Roussel Uclaf Nouveau procede de preparation de l'hydrocortisone et nouveaux intermediaires.
GB9201224D0 (en) * 1992-01-21 1992-03-11 Erba Carlo Spa Difluoromethylenandrostenone derivatives and process for their preparation
GB9217035D0 (en) * 1992-08-11 1992-09-23 Erba Carlo Spa Androst-4-eno(4,5-b)pyrrole derivatives and process for their preparation
AU666433B2 (en) * 1993-02-18 1996-02-08 Pharmacia & Upjohn S.P.A. Fluorinated 4-aminoandrostadienone derivatives and process for their preparation
DE10104327A1 (de) * 2001-01-24 2002-07-25 Schering Ag 11beta-Halogensteroide, deren Herstellung und Verwendung zur Herstellung von Arzneimitteln sowie 11beta-Halogensteroide enthaltende pharmazeutische Präparate
CN1713915A (zh) * 2001-10-10 2005-12-28 法马西亚意大利公司 用甾族化合物预防和治疗骨丢失的方法
US7435757B2 (en) * 2004-07-02 2008-10-14 Schering Ag 2-substituted D-homo-estra-1,3,5(10)-trienes as inhibitors of 17β-hydroxy steroid dehydrogenase type 1
US20060211667A1 (en) * 2005-03-21 2006-09-21 Eric Marchewitz Use of pregnane steroid derivatives for enhancing physical performance
EP1854465A1 (en) 2006-05-12 2007-11-14 Alexander Tobias Teichmann Use of 4,17 beta-dihydroxyandrost-4-ene-3-one for treating cancers
ES2574933T3 (es) 2007-11-13 2016-06-23 Athenion Ag Esteroides de C-19 para usos cosméticos
EP2949361B1 (en) 2007-11-13 2017-03-22 Athenion AG C-19 steroids for treating cellulite

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB929985A (es) *
GB8517360D0 (en) * 1985-07-09 1985-08-14 Erba Farmitalia Substituted androsta-1,4-diene-3,17-diones

Also Published As

Publication number Publication date
IL87656A (en) 1993-02-21
EP0307135B1 (en) 1992-08-19
SU1750431A3 (ru) 1992-07-23
FI884088A (fi) 1989-03-12
EP0307135A1 (en) 1989-03-15
JPH01104096A (ja) 1989-04-21
FI884088A0 (fi) 1988-09-06
ATE79629T1 (de) 1992-09-15
FI88393C (fi) 1993-05-10
DE3873862D1 (de) 1992-09-24
DE3873862T2 (de) 1993-01-14
GR3005961T3 (es) 1993-06-07
AU602607B2 (en) 1990-10-18
GB8721384D0 (en) 1987-10-21
US4873233A (en) 1989-10-10
KR890005142A (ko) 1989-05-13
IL87656A0 (en) 1989-02-28
AU2197988A (en) 1989-03-16
KR970007948B1 (ko) 1997-05-19
FI88393B (fi) 1993-01-29
JP2677626B2 (ja) 1997-11-17
CA1305699C (en) 1992-07-28

Similar Documents

Publication Publication Date Title
ES2056962T3 (es) Un procedimiento para la preparacion de nuevos derivados de camptotecina.
ES2082805T3 (es) Derivados de tiazol, procedimientos para su produccion y composiciones farmaceuticas que comprenden los mismos.
ATE52498T1 (de) Amidderivate.
FI965020A (fi) Uusia yhdisteitä, menetelmiä niiden valmistamiseksi ja kasvaintenvastaisia aineita
ES2112386T3 (es) Agentes terapeuticos para uso en el tratamiento de la enfermedad de parkinson.
ES2043834T3 (es) Un procedimiento para preparar nuevos derivados de androsta-1,4-dien-3-ona sustituida en la posicion 17.
DE69013959D1 (de) Aminobenzolsulfonsäurederivate.
PT96226A (pt) Processo para a preparacao de derivados morfolinilicos de doxorubicina e de composicoes farmaceuticas que os contem
DK364787A (da) 6- eller 7-methylenandrosta-1,4-dien-3,17-dion-derivater og fremgangsmaade til fremstilling deraf
ES2169220T3 (es) Derivados de vitamina d3 con sustituyentes en la posicion 2.
ATE168367T1 (de) Vitamin-d-derivate und verfahren zu deren herstellung
ES2096572T3 (es) Nuevos derivados de glucosidos de antraciclina y procedimiento para su preparacion.
EP0785190A3 (es)
FI940011A (fi) Mono- ja bis-alkyyliaminoantrasykliinit
NZ216922A (en) 6-amino-androsta-1,4-diene-3,17-dione derivatives and pharmaceutical compositions
ES533657A0 (es) Un procedimiento para la preparacion de nuevos derivados de pirrolo-(2,1-a)isoquilonina.
EP1112998A4 (en) AMINE DERIVATIVES
DK0424248T3 (da) 20,21-dinoreburnamein med substitution i 15-stillingen, fremgangsmåde til deres fremstilling samt mellemprodukter til brug derved, deres anvendelse som lægemidler og præparater med indhold deraf
DE69917236D1 (de) Heterocyclische anthracyclinonderivate

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 307135

Country of ref document: ES